Nvidia Invests $50M into AI Drug Discovery Firm Recursion
Om avsnittet
In this episode, we delve into Nvidia's substantial $50M investment in Recursion, a leading firm in AI drug discovery. We'll explore the strategic implications of this partnership, discuss how it might accelerate the application of AI in pharmaceutical research, and consider its potential to revolutionize drug discovery.
Get on the AI Box Waitlist: https://AIBox.ai/
Investor Contact Email: [email protected]
Sponsor the Podcast: [email protected]
Facebook Community: https://www.facebook.com/groups/739308654562189/
Discord Community: https://aibox.ai/discord
Download Selfpause: https://selfpause.com/Podcast
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
AI Chat: AI News & Artificial Intelligence med Jaeden Schafer finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.